Acadia Healthcare Reports 78.1% Growth in Second Quarter Adjusted EPS to $0.57
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Acadia Healthcare (ACHC) PT Raised to $90 at UBS on Emerging Substance Abuse Opportunity in the UK
August 6, 2015 8:17 AM EDTUBS analyst A.J. Rice reiterated a Buy rating and raised his price target on Acadia Healthcare (NASDAQ: ACHC) to $90.00 (from $85.00) following Q2 results as they see emerging substance abuse opportunity in the UK.
Rice commented, "ACHC announced the acquisition of a 15-bed... More
Acadia Healthcare (ACHC) Tops Q2 EPS by 5c, Raises FY EPS Guidance
August 4, 2015 5:44 PM EDTAcadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.57, $0.05 better than the analyst estimate of $0.52. Revenue for the quarter came in at $453.7 million versus the consensus estimate of $433.84 million.
Acadia Healthcare sees FY2015 EPS of $2.15-$2.18, versus prior guidance of $2.12-$2.15 and the consensus of... More
